Investigational Drug Information for tricaprilin
✉ Email this page to a colleague
What is the drug development status for tricaprilin?
tricaprilin is an investigational drug.
There have been 14 clinical trials for tricaprilin.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2024.
The most common disease conditions in clinical trials are Alzheimer Disease, Spasms, Infantile, and Spasm. The leading clinical trial sponsors are Cerecin, Accera, Inc., and [disabled in preview].
There are seventy-three US patents protecting this investigational drug and two international patents.
Summary for tricaprilin
| US Patents | 73 |
| International Patents | 2,818 |
| US Patent Applications | 1,396 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 5,119 |
| Clinical Trial Progress | Phase 2 (2024-01-01) |
| Vendors | 80 |
Recent Clinical Trials for tricaprilin
| Title | Sponsor | Phase |
|---|---|---|
| Tricaprilin Phase 3 AD Study | Cerecin | Phase 3 |
| AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions | Cerecin | Phase 1 |
| A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects | Cerecin | Phase 1 |
Clinical Trial Summary for tricaprilin
Top disease conditions for tricaprilin
Top clinical trial sponsors for tricaprilin
US Patents for tricaprilin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tricaprilin | ⤷ Try a Trial | Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse | Acura Pharmaceuticals, Inc. (Palatine, IL) | ⤷ Try a Trial |
| Tricaprilin | ⤷ Try a Trial | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) | DANA-FARBER CANCER INSTITUTE, INC. (Boston, MA) | ⤷ Try a Trial |
| Tricaprilin | ⤷ Try a Trial | Oxymorphone transdermal patch | BUZZZ PHARMACEUTICALS LIMITED (Dublin, IE) | ⤷ Try a Trial |
| Tricaprilin | ⤷ Try a Trial | Hair care compositions | DSM IP ASSETS B.V. (Heerlen, NL) | ⤷ Try a Trial |
| Tricaprilin | ⤷ Try a Trial | Lipidic furan, pyrrole, and thiophene compounds for treatment of cancer, neurological disorders, and fibrotic disorders | Avoscience, LLC (Hayden, ID) | ⤷ Try a Trial |
| Tricaprilin | ⤷ Try a Trial | RM2 antigens and use thereof | ACADEMIA SINICA (Taipei, TW) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for tricaprilin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tricaprilin | World Intellectual Property Organization (WIPO) | WO2017083117 | 2035-11-10 | ⤷ Try a Trial |
| Tricaprilin | World Intellectual Property Organization (WIPO) | WO2017083118 | 2035-11-10 | ⤷ Try a Trial |
| Tricaprilin | China | CN103189046 | 2030-09-09 | ⤷ Try a Trial |
| Tricaprilin | China | CN106074278 | 2030-09-09 | ⤷ Try a Trial |
| Tricaprilin | World Intellectual Property Organization (WIPO) | WO2012033634 | 2030-09-09 | ⤷ Try a Trial |
| Tricaprilin | Australia | AU2015274936 | 2034-06-09 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
